HealthyNCT04357886
Awareness of COVID-19 in Turkey
An observational study of Healthy, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).
Trial summary
Because COVID-19 is a new virus, it is believed that awareness assessment will inform and guide what steps should be taken and which groups should be targeted in terms of controlling the pandemic. Read more about this study
- Who is it for?
- Ages 15 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- How many people
- 2,605 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 May 2020to 1 Jun 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 65 years
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: people of diffirent age groups throughout Turkey
Who may be able to join
- Having at least primary education
- Being literate in Turkish
- There is a level of cooperation to understand the evaluations
- Agree to participate in the study
Who cannot join
- Those with audio and visual problems that prevent communication
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Comparison of New Coronavirus (COVID-19) Awareness in Individuals of Different Age Groups: Analysis of Turkey
Because COVID-19 is a new virus, it is believed that awareness assessment will inform and guide what steps should be taken and which groups should be targeted in terms of controlling the pandemic. According to our hypothesis, COVID-19 awareness of individuals in different age groups in the Turkish population also varies. There are controlling pratices based on scientific studies made during the outbreak, but there is no certainty as to how much these measures are known by our society. Based on these, the aim of our study was to investigate and compare the awareness of new Coronavirus (COVID-19) in different age groups across Turkey.
Read the detailed description
Statistical Analysis: In the statistical analysis of the data obtained at the end of the study, SPSS (Statistical Package for Social Sciences / SPSS 21.0) was analyzed using the statistical program. In the study, arithmetic averages are presented with tables and graphs as mean ± SD (standard deviation) and values indicated by counting in numbers (percent). Demographic information of the participants and their responses to the questionnaire questions were evaluated using descriptive statistical analysis method. In the study, Independent Sample t Test was used in parametric data and ANOVA was used in normal non-parametric data. In all analyzes, p <0,05 was considered statistically significant.
Sampling: Sample size was calculated based on the number of questions asked. Accordingly, the number of questions multiplied by the formula of 60 is the lower limit (42*60=2520). Considering the 20% probability of a drop-out and the fact that participants did not want to volunteer, it was decided to take 3150 people to the study. Consent will be obtained from the participants through a voluntary information form.
- Conditions
- Healthy
- Keywords
- COVID-19, Pandemic, Knowledge and Awareness, Adolescent, Adults
- Medical subject headings
- COVID-19
What is being measured
The primary outcome is the main question the study is designed to answer.
COVID-19 Awareness Survey
The questionnaire was prepared by the researchers. There are 49 questions in the survey and all of them are multiple choice. The survey assesses the demographic characteristics, awareness and attitudes of the participants towards the COVID-19.
Measured: once at baseline of study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Apr 2020
- Study start15 May 2020
- Primary completion1 Jun 2020
- Study completion1 Jun 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for HealthyStudies of the same condition, open and under way.
- More trials run by Istanbul University - CerrahpasaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 2,605 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul University - Cerrahpasa
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Saliha Gürdal Karakelle, Istanbul University - Cerrahpasa
- Investigators
- Ipek Yeldan, PhD, Study director, Istanbul University - Cerrahpasa
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04357886
- Sponsor's protocol ID
- 60350273-605.99-
- Status last verified
- Mar 2021
- First submitted
- 20 Apr 2020
- Last updated
- 26 Mar 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
PubMed 32113704Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020 May;55(5):105951. doi: 10.1016/j.ijantimicag.2020.105951. Epub 2020 Mar 29.
PubMed 32234466
Study at a glance
From the registry record, last updated by the sponsor on 26 Mar 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Comparison of New Coronavirus (COVID-19) Awareness in Individuals of Different Age Groups: Analysis of Turkey
- ClinicalTrials.gov ID
- NCT04357886
- Acronym / sponsor ID
- 60350273-605.99-
- Conditions
- Healthy
- Keywords
- COVID-19, Pandemic, Knowledge and Awareness, Adolescent, Adults
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 2,605 participants (actual)
- Lead sponsor
- Istanbul University - CerrahpasaUniversity, hospital or other
- Study start
- 15 May 2020 (actual)
- Primary completion
- 1 Jun 2020 (actual)
- Study completion
- 1 Jun 2020 (actual)
- First posted
- 22 Apr 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Because COVID-19 is a new virus, it is believed that awareness assessment will inform and guide what steps should be taken and which groups should be targeted in terms of controlling the pandemic. According to our hypothesis, COVID-19 awareness of individuals in different age groups in the Turkish population also varies. There are controlling pratices based on scientific studies made during the outbreak, but there is no certainty as to how much these measures are known by our society. Based on these, the aim of our study was to investigate and compare the awareness of new Coronavirus (COVID-19) in different age groups across Turkey.
Detailed description
Statistical Analysis: In the statistical analysis of the data obtained at the end of the study, SPSS (Statistical Package for Social Sciences / SPSS 21.0) was analyzed using the statistical program. In the study, arithmetic averages are presented with tables and graphs as mean ± SD (standard deviation) and values indicated by counting in numbers (percent). Demographic information of the participants and their responses to the questionnaire questions were evaluated using descriptive statistical analysis method. In the study, Independent Sample t Test was used in parametric data and ANOVA was used in normal non-parametric data. In all analyzes, p <0,05 was considered statistically significant.
Sampling: Sample size was calculated based on the number of questions asked. Accordingly, the number of questions multiplied by the formula of 60 is the lower limit (42*60=2520). Considering the 20% probability of a drop-out and the fact that participants did not want to volunteer, it was decided to take 3150 people to the study. Consent will be obtained from the participants through a voluntary information form.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 15 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- people of diffirent age groups throughout Turkey
Key inclusion criteria (4 listed)
- Having at least primary education
- Being literate in Turkish
- There is a level of cooperation to understand the evaluations
- Agree to participate in the study
Key exclusion criteria (1 listed)
- Those with audio and visual problems that prevent communication
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
COVID-19 Awareness Survey
Time frame: once at baseline of study
The questionnaire was prepared by the researchers. There are 49 questions in the survey and all of them are multiple choice. The survey assesses the demographic characteristics, awareness and attitudes of the participants towards the COVID-19.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Mar 2021.
- Background: PubMed 32113704Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
- Background: PubMed 32234466Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020 May;55(5):105951. doi: 10.1016/j.ijantimicag.2020.105951. Epub 2020 Mar 29.
- access to current data about the COVID-19 in the worldLink provided by the sponsor.
- access to current data about the COVID-19 in TurkeyLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ipek Yeldan, PhD study director
Istanbul University - Cerrahpasa
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Healthy, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
COVID-19 Awareness Survey (time frame: once at baseline of study). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04357886, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2021.